{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T02:39:24Z","timestamp":1788143964480,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jinhua Traditional Chinese Medicine Science and Technology Research Program","award":["2023KY34"],"award-info":[{"award-number":["2023KY34"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-025-03738-5","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T12:13:27Z","timestamp":1756815207000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Jueling Mingmu decoction combined with ranibizumab for retinal vein occlusion induced macular edema: A randomized controlled clinical trial"],"prefix":"10.1007","volume":"45","author":[{"given":"Wu","family":"Hongyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Hangshuai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"issue":"10266","key":"3738_CR1","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1016\/S0140-6736(20)31559-2","volume":"396","author":"IU Scott","year":"2020","unstructured":"Scott IU, Campochiaro PA, Newman NJ, Biousse V (2020) Retinal vascular occlusions. Lancet 396(10266):1927\u20131940","journal-title":"Lancet"},{"issue":"2","key":"3738_CR2","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ophtha.2009.07.017","volume":"117","author":"S Rogers","year":"2010","unstructured":"Rogers S, McIntosh RL, Cheung N, Lim L, Wang JJ, Mitchell P, Kowalski JW, Nguyen H, Wong TY (2010) International eye disease C: The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology 117(2):313-319 e311","journal-title":"Ophthalmology"},{"issue":"3","key":"3738_CR3","first-page":"335","volume":"36","author":"P Kalva","year":"2023","unstructured":"Kalva P, Akram R, Zuberi HZ, Kooner KS (2023) Prevalence and risk factors of retinal vein occlusion in the United States: the national health and nutrition examination survey, 2005 to 2008. Proc (Bayl Univ Med Cent) 36(3):335\u2013340","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"3738_CR4","unstructured":"Cochran ML, Mahabadi N, Czyz CN (2024) Branch retinal vein occlusion. In: StatPearls. edn. Treasure Island (FL)."},{"key":"3738_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000004244","author":"N Gomel","year":"2024","unstructured":"Gomel N, D\u2019Aloisio R, Wattad A, Mastropasqua R, Formenti F, Loewenstein A, Iglicki M, Zur D (2024) Good initial visual acuity in patients with macular edema due to retinal vein occlusion - management and outcomes. Retina. https:\/\/doi.org\/10.1097\/IAE.0000000000004244","journal-title":"Retina"},{"issue":"12","key":"3738_CR6","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1016\/j.ophtha.2006.05.056","volume":"113","author":"MB Parodi","year":"2006","unstructured":"Parodi MB, Spasse S, Iacono P, Di Stefano G, Canziani T, Ravalico G (2006) Subthreshold grid laser treatment of macular edema secondary to branch retinal vein occlusion with micropulse infrared (810 nanometer) diode laser. Ophthalmology 113(12):2237\u20132242","journal-title":"Ophthalmology"},{"issue":"3","key":"3738_CR7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1136\/bjophthalmol-2014-305041","volume":"99","author":"H Gerding","year":"2015","unstructured":"Gerding H, Mones J, Tadayoni R, Boscia F, Pearce I, Priglinger S (2015) Ranibizumab in retinal vein occlusion: treatment recommendations by an expert panel. Br J Ophthalmol 99(3):297\u2013304","journal-title":"Br J Ophthalmol"},{"key":"3738_CR8","doi-asserted-by":"publisher","first-page":"5948113","DOI":"10.1155\/2021\/5948113","volume":"2021","author":"YH Bae","year":"2021","unstructured":"Bae YH, Kim SM, Kim JY, Bae SH, Kim H, Ma DJ (2021) Effect of alternate treatment with intravitreal corticosteroid and anti-VEGF for Macular Edema secondary to retinal vein occlusion. J Ophthalmol 2021:5948113","journal-title":"J Ophthalmol"},{"issue":"3","key":"3738_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000502041","volume":"242","author":"U Schmidt-Erfurth","year":"2019","unstructured":"Schmidt-Erfurth U, Garcia-Arumi J, Gerendas BS, Midena E, Sivaprasad S, Tadayoni R, Wolf S, Loewenstein A (2019) Guidelines for the management of retinal vein occlusion by the European Society of Retina Specialists (EURETINA). Ophthalmologica 242(3):123\u2013162","journal-title":"Ophthalmologica"},{"issue":"2","key":"3738_CR10","doi-asserted-by":"publisher","first-page":"P288","DOI":"10.1016\/j.ophtha.2019.09.029","volume":"127","author":"CJ Flaxel","year":"2020","unstructured":"Flaxel CJ, Adelman RA, Bailey ST, Fawzi A, Lim JI, Vemulakonda GA, Ying GS (2020) Retinal vein occlusions preferred practice pattern(R). Ophthalmology 127(2):P288\u2013P320","journal-title":"Ophthalmology"},{"issue":"7","key":"3738_CR11","first-page":"1304","volume":"61","author":"RB Bhisitkul","year":"2020","unstructured":"Bhisitkul RB, Blotner S, Steffen V, Haskova Z (2020) Clinical trial versus real-world outcomes with anti-VEGF therapy for central retinal vein occlusion. Invest Ophthalmol Vis Sci 61(7):1304\u20131304","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"3738_CR12","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1136\/bjophthalmol-2020-317337","volume":"105","author":"T Ciulla","year":"2021","unstructured":"Ciulla T, Pollack JS, Williams DF (2021) Visual acuity outcomes and anti-VEGF therapy intensity in macular oedema due to retinal vein occlusion: a real-world analysis of 15 613 patient eyes. Br J Ophthalmol 105(12):1696\u20131704","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"3738_CR13","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.ophtha.2016.02.030","volume":"123","author":"R Tadayoni","year":"2016","unstructured":"Tadayoni R, Waldstein SM, Boscia F, Gerding H, Pearce I, Priglinger S, Wenzel A, Barnes E, Gekkieva M, Pilz S et al (2016) Individualized stabilization criteria-driven ranibizumab versus laser in branch retinal vein occlusion: six-month results of BRIGHTER. Ophthalmology 123(6):1332\u20131344","journal-title":"Ophthalmology"},{"issue":"7","key":"3738_CR14","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.ophtha.2015.04.006","volume":"122","author":"PA Campochiaro","year":"2015","unstructured":"Campochiaro PA, Hafiz G, Mir TA, Scott AW, Solomon S, Zimmer-Galler I, Sodhi A, Duh E, Ying H, Wenick A et al (2015) Scatter photocoagulation does not reduce macular edema or treatment burden in patients with retinal vein occlusion: the RELATE trial. Ophthalmology 122(7):1426\u20131437","journal-title":"Ophthalmology"},{"issue":"4","key":"3738_CR15","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/IAE.0000000000003698","volume":"43","author":"MK Soliman","year":"2023","unstructured":"Soliman MK, Zarranz-Ventura J, Chakravarthy U, McKibbin M, Brand C, Menon G, Cilliers H, Natha S, Ross A, Sarhan M et al (2023) United Kingdom database study of intravitreal dexamethasone implant (Ozurdex) for macular edema related to retinal vein occlusion. Retina 43(4):679\u2013687","journal-title":"Retina"},{"issue":"4","key":"3738_CR16","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1177\/1120672120947595","volume":"31","author":"R Pranata","year":"2021","unstructured":"Pranata R, Vania A, Vania R, Victor AA (2021) Intravitreal ranibizumab versus dexamethasone implant in macular edema due to branch retinal vein occlusion: systematic review and meta-analysis. Eur J Ophthalmol 31(4):1907\u20131914","journal-title":"Eur J Ophthalmol"},{"issue":"9","key":"3738_CR17","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.18240\/ijo.2022.09.15","volume":"15","author":"XY Qiu","year":"2022","unstructured":"Qiu XY, Hu XF, Qin YZ, Ma JX, Liu QP, Qin L, Li JM (2022) Comparison of intravitreal aflibercept and dexamethasone implant in the treatment of macular edema associated with diabetic retinopathy or retinal vein occlusion: a meta-analysis and systematic review. Int J Ophthalmol 15(9):1511\u20131519","journal-title":"Int J Ophthalmol"},{"key":"3738_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.119869","volume":"348","author":"J Lei","year":"2025","unstructured":"Lei J, Gong D, Duan L, Tang R, Gu W, Zhang F, Zhao Y, Zhang M, Yang X, Yu J (2025) A multidimensional perspective on Poria cocos, an ancient fungal traditional Chinese medicine. J Ethnopharmacol 348:119869","journal-title":"J Ethnopharmacol"},{"key":"3738_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156461","volume":"139","author":"S Dong","year":"2025","unstructured":"Dong S, Zhang Y, Xie Y, Ouyang H, Zhou S, Shi J, Lu B, Mei X, Ji L (2025) Uncovering the potential mechanism and bioactive compounds of Salviae Miltiorrhizae Radix et Rhizoma in attenuating diabetic retinopathy. Phytomedicine 139:156461","journal-title":"Phytomedicine"},{"key":"3738_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115547","volume":"167","author":"Y Yang","year":"2023","unstructured":"Yang Y, Wang Y, Deng Y, Lu J, Xiao L, Li J, Zhou Y, Nie F, Chen X, Peng J et al (2023) Fructus lycii and Salvia miltiorrhiza Bunge extract attenuate oxidative stress-induced photoreceptor ferroptosis in retinitis pigmentosa. Biomed Pharmacother 167:115547","journal-title":"Biomed Pharmacother"},{"key":"3738_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9521379","author":"P Long","year":"2019","unstructured":"Long P, Yan W, Liu J, Li M, Chen T, Zhang Z, An J (2019) Therapeutic effect of traditional Chinese medicine on a rat model of branch retinal vein occlusion. J Ophthalmol. https:\/\/doi.org\/10.1155\/2019\/9521379","journal-title":"J Ophthalmol"},{"issue":"2","key":"3738_CR22","first-page":"305","volume":"40","author":"B Lu","year":"2020","unstructured":"Lu B, Wu X (2020) Effect of Lingqi Huangban granule plus intravitreal ranibizumab on macular edema induced by retinal vein occlusion: a randomized controlled clinical trial. J Tradit Chin Med 40(2):305\u2013310","journal-title":"J Tradit Chin Med"},{"issue":"12","key":"3738_CR23","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1001\/jamaophthalmol.2018.4973","volume":"136","author":"IL McAllister","year":"2018","unstructured":"McAllister IL, Smithies LA, Chen FK, Mackey DA, Sanfilippo PG (2018) Two-year efficacy of ranibizumab plus laser-induced chorioretinal anastomosis vs ranibizumab monotherapy for central retinal vein occlusion: a randomized clinical trial. JAMA Ophthalmol 136(12):1391\u20131397","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"3738_CR24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.survophthal.2022.11.008","volume":"68","author":"OA Sorour","year":"2023","unstructured":"Sorour OA, Levine ES, Baumal CR, Elnahry AG, Braun P, Girgis J, Waheed NK (2023) Persistent diabetic macular edema: Definition, incidence, biomarkers, and treatment methods. Surv Ophthalmol 68(2):147\u2013174","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"3738_CR25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.oret.2017.05.016","volume":"2","author":"Larsen M, Waldstein SM, Priglinger S, Hykin P, Barnes E, Gekkieva M, Das Gupta A, Wenzel A, Mones J, Group CS","year":"2018","unstructured":"Larsen M, Waldstein SM, Priglinger S, Hykin P, Barnes E, Gekkieva M, Das Gupta A, Wenzel A, Mones J, Group CS (2018) Sustained benefits from ranibizumab for central retinal vein occlusion with macular edema: 24-month results of the CRYSTAL study. Ophthalmol Retina 2(2):134\u2013142","journal-title":"Ophthalmol Retina"},{"issue":"6","key":"3738_CR26","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/s41433-021-01620-z","volume":"36","author":"KL Spooner","year":"2022","unstructured":"Spooner KL, Fraser-Bell S, Hong T, Wong JG, Chang AA (2022) Long-term outcomes of anti-VEGF treatment of retinal vein occlusion. Eye (Lond) 36(6):1194\u20131201","journal-title":"Eye (Lond)"},{"issue":"11","key":"3738_CR27","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1016\/j.ophtha.2014.05.031","volume":"121","author":"IL McAllister","year":"2014","unstructured":"McAllister IL, Tan MH, Smithies LA, Wong WL (2014) The effect of central retinal venous pressure in patients with central retinal vein occlusion and a high mean area of nonperfusion. Ophthalmology 121(11):2228\u20132236","journal-title":"Ophthalmology"},{"issue":"12","key":"3738_CR28","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1007\/s40123-024-01042-6","volume":"13","author":"C Dinah","year":"2024","unstructured":"Dinah C, Chang A, Lee J, Li WW, Singh R, Wu L, Wong D, Saffar I (2024) What is occluding our understanding of retinal vein occlusion? Ophthalmol Ther 13(12):3025\u20133034","journal-title":"Ophthalmol Ther"},{"key":"3738_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4823677","author":"S Xiaojuan","year":"2022","unstructured":"Xiaojuan S, Xiaodong L, Zhongmei F, Hejiang Y (2022) Chinese herbal medicine combined with intravitreal antivascular growth factor agents in treatment of macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis. J Ophthalmol. https:\/\/doi.org\/10.1155\/2022\/4823677","journal-title":"J Ophthalmol"},{"issue":"7","key":"3738_CR30","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1080\/02713683.2024.2327055","volume":"49","author":"H Ren","year":"2024","unstructured":"Ren H, Sun Y, Li Y, Yuan X, Jiang B, Zhang W, Liu G, Lu P (2024) Potential mechanism of platelet GPIIb\/IIIa and fibrinogen on retinal vein occlusion. Curr Eye Res 49(7):731\u2013741","journal-title":"Curr Eye Res"},{"key":"3738_CR31","doi-asserted-by":"crossref","unstructured":"Bohm EW, Buonfiglio F, Korb CA, Dauth A, Pfeiffer N, Breborowicz A, Gericke A (2024) Potential of sulodexide in the treatment of diabetic retinopathy and retinal vein occlusion. Thromb Haemost.","DOI":"10.1055\/s-0044-1791232"},{"issue":"5","key":"3738_CR32","doi-asserted-by":"publisher","first-page":"876","DOI":"10.18240\/ijo.2025.05.13","volume":"18","author":"G Karatas","year":"2025","unstructured":"Karatas G, Cakir A, Uzundede T, Aday O, Ozoguz AM, Karatas ME, Kabakci AK (2025) Dexamethasone intravitreal implant monotherapy in naive patients with macular edema secondary to retinal vein occlusion: long term follow-up retrospective cohort study. Int J Ophthalmol 18(5):876\u2013882","journal-title":"Int J Ophthalmol"},{"issue":"3","key":"3738_CR33","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.ophtha.2015.10.030","volume":"123","author":"TA Mir","year":"2016","unstructured":"Mir TA, Kherani S, Hafiz G, Scott AW, Zimmer-Galler I, Wenick AS, Solomon S, Han I, Poon D, He L et al (2016) Changes in retinal Nonperfusion associated with suppression of vascular endothelial growth factor in retinal vein occlusion. Ophthalmology 123(3):625\u2013634","journal-title":"Ophthalmology"},{"issue":"6","key":"3738_CR34","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s10384-020-00765-w","volume":"64","author":"R Osaka","year":"2020","unstructured":"Osaka R, Muraoka Y, Nakano Y, Takasago Y, Koyama Y, Miyoshi Y, Tsujikawa A, Suzuma K (2020) One-year results of anti-vascular endothelial growth factor therapy combined with triamcinolone acetonide for macular edema associated with branch retinal vein occlusion. Jpn J Ophthalmol 64(6):605\u2013612","journal-title":"Jpn J Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03738-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-025-03738-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03738-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:04:34Z","timestamp":1766167474000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-025-03738-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3738"],"URL":"https:\/\/doi.org\/10.1007\/s10792-025-03738-5","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Have been granted by the Institutional Ethical Committee of Dongyang People's Hospital, with reference number Dongrenyi 2023-YX-346. Informed consent will be obtained from all study participants upon their recruitment.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"372"}}